NPI: 1871548263 · NORTH ANDOVER, MA 01845 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,034 | $501K |
| 2019 | 29,105 | $476K |
| 2020 | 26,712 | $261K |
| 2021 | 25,165 | $327K |
| 2022 | 24,401 | $720K |
| 2023 | 14,690 | $805K |
| 2024 | 10,132 | $628K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 67,691 | 5,421 | $3.71M |
| A4657 | Syringe, with or without needle, each | 6,374 | 3,288 | $6K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 42,190 | 2,487 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 7,761 | 2,089 | $0.00 |
| 85041 | 2,515 | 2,451 | $0.00 | |
| 83970 | 2,606 | 2,157 | $0.00 | |
| 85048 | 2,493 | 2,431 | $0.00 | |
| 83540 | 1,615 | 1,587 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 567 | 354 | $0.00 |
| 90662 | 77 | 77 | $0.00 | |
| 82108 | 218 | 216 | $0.00 | |
| 85045 | 14 | 13 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 144 | 12 | $0.00 |
| 83550 | 1,368 | 1,348 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,399 | 1,699 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,188 | 934 | $0.00 |
| 82728 | 1,532 | 1,507 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 120 | 120 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 352 | 202 | $0.00 |
| 90674 | 15 | 15 | $0.00 |